EFFECTIVENESS OF INTERMITTENTLY SCANNED CONTINUOUS GLUCOSE MONITORING IN A PREGNANT WOMAN WITH POORLY CONTROLLED TYPE 1 DIABETES AND END-STAGE RENAL DISEASE: A CASE REPORT

被引：0
|
作者：
Nicoli, F. [1 ]
Citro, F. [1 ]
Bianchi, C. [2 ]
Aragona, M. [2 ]
Battini, L. [3 ]
Del Prato, S. [1 ]
Bertolotto, A. [2 ]
机构：
[1] Univ Pisa, Clin & Expt Med, Pisa, Italy
[2] Univ Hosp Pisa, Dept Med, Pisa, Italy
[3] Univ Hosp Pisa, Maternal Infant Dept, Pisa, Italy
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2023年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
579
引用
收藏
页码：A208 / A209
页数：2
相关论文
共 50 条
  • [41] Intermittently scanned continuous glucose monitoring is associated with a long-term glucose-lowering effect for type 1 diabetes patients in poor glycaemic control
    Jensen, M. H.
    Cichosz, S. L.
    Gustenhoff, P.
    Nikontovic, A.
    Hejlesen, O.
    Vestergaard, P.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S52 - S52
  • [42] Interest of Continuous Glucose Monitoring to Improve Glycemic Control in Patients With Type 2 Diabetes and End-Stage Renal Disease Treated by Basal-Bolus Insulin Regimen
    Kepenekian, Lori
    Smagala, Agnieszka
    Meyer, Laurent
    Imhoff, Olivier
    Sissoko, Aicha
    Serb, Liviu
    Krummel, Thierry
    Dorey, Francois
    Fleury, Dominique
    Le Floch, Jean-Pierre
    Chantrel, Francois
    Kessler, Laurence
    DIABETES, 2013, 62 : A227 - A227
  • [43] Continuous glucose monitoring (CGM) for effective glucose control in a pregnant woman living with type IIIa glycogenosis. A case report
    Bonnet, Jean-Baptiste
    Fasolo, Martina
    Marty, Lucile
    Galibert, Laetitia
    Richard, Celine Dupy
    Sultan, Ariane
    Attalin, Vincent
    Avignon, Antoine
    CLINICAL NUTRITION ESPEN, 2024, 64 : 519 - 524
  • [44] COMPARING REAL-TIME AND INTERMITTENTLY SCANNED CONTINUOUS GLUCOSE MONITORING IN ADULTS WITH TYPE 1 DIABETES: THE SIX-MONTH MULTICENTER RANDOMIZED CONTROLLED ALERTT1 TRIAL
    Visser, M.
    Charleer, S.
    Fieuws, S.
    Hilbrands, R.
    Maes, T.
    De Block, C.
    Vanhaverbeke, G.
    Dirinck, E.
    Myngheer, N.
    Nobels, F.
    Keymeulen, B.
    Mathieu, C.
    Gillard, P.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A30 - A31
  • [45] Safety and Effectiveness of Insulin Analogs in People with Type 2 Diabetes and End-Stage Renal Disease in the A1chieve Study
    Khochtali, Ines
    Khamseh, Mohamed E.
    Fasanmade, Olufemi A.
    Chen, Jian-Wen
    Hajjaji, Issam M.
    DIABETES, 2014, 63 : A141 - A141
  • [46] The social determinants of health for people with type 1 diabetes that progress to end-stage renal disease
    Hill, Kathleen E.
    Gleadle, Jonathan M.
    Pulvirenti, Mariastella
    McNaughton, Darlene A.
    HEALTH EXPECTATIONS, 2015, 18 (06) : 2513 - 2521
  • [47] Association of PVT1 variants with end-stage renal disease attributed to type 1 diabetes
    Millis, Meredith P.
    Bowen, Danielle
    Watanabe, Richard M.
    Wolford, Johanna K.
    DIABETES, 2007, 56 : A289 - A289
  • [48] Euglycemic diabetic ketoacidosis in a woman with type I diabetes, end-stage renal disease and COVID-19 infection
    Tchaconas, Alexis
    Truglio, Joseph
    PEDIATRICS, 2021, 147 (03)
  • [49] Continuous interstitial glucose monitoring in non-diabetic subjects with end-stage renal disease undergoing maintenance haemodialysis
    Sobngwi, E.
    Ashuntantang, G.
    Ndounia, E.
    Dehayem, M.
    Azabji-Kenfack, M.
    Kaze, F.
    Balti, E.
    Mbanya, J. C.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2010, 90 (01) : 22 - 25
  • [50] Cost-Effectiveness of Intermittently Scanned Continuous Glucose Monitoring Versus Advanced Hybrid Closed-Loop Systems in Type 1 Diabetes: Comment on Jendle et al.
    Levrat-Guillen, Fleur
    Ghazi, Tara
    DIABETES THERAPY, 2022, 13 (05) : 1121 - 1123
12345